Expertise in
11
conditions

Wassim Kassouf

1650 Cedar Avenue, 
Montreal, QC, CA 
Expertise in
11
conditions
1650 Cedar Avenue, 
Montreal, QC, CA 

Overview

Wassim Kassouf practices practicing medicine in Montreal, Canada.

Mr. Kassouf is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy.

He is actively involved in clinical research, co-authoring 294 peer reviewed articles and participating in 5 clinical trials.

Gender

Male

Locations

1650 Cedar Avenue, Montreal, QC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
Triple-tracer Molecular Imaging Using 18F-FDG, 68Ga-PSMA and 68Ga-OCTREOTATE to Characterize Metastatic Castration-resistant Prostate Cancer (mCRPC) and Evaluate Eligibility for Radionuclide Therapies
Triple-tracer Molecular Imaging Using 18F-FDG, 68Ga-PSMA and 68Ga-OCTREOTATE to Characterize Metastatic Castration-resistant Prostate Cancer (mCRPC) and Evaluate Eligibility for Radionuclide Therapies
Enrollment Status: Completed
Publish Date: August 28, 2023
Intervention Type: Diagnostic test, Other
Tranexamic Acid During Cystectomy Trial (TACT)
Tranexamic Acid During Cystectomy Trial (TACT)
Enrollment Status: Completed
Publish Date: October 04, 2022
Intervention Type: Drug
Study Drug: Tranexamic Acid
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials

294 Total Publications

Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group.
Journal: Nature reviews. Urology
Published: July 22, 2026

Frequently Asked Questions about Wassim Kassouf

Is Wassim Kassouf a top-rated expert for Muscle Invasive Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Wassim Kassouf is classified as an Elite expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Wassim Kassouf participate in research or clinical trials?

Yes. Wassim Kassouf has published 294 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Wassim Kassouf's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kassouf's expertise for a condition
ConditionClose
View All 7 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile